查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1771643

多体学市场规模、份额、趋势分析报告（按产品与服务、类型、平台、应用、最终用途、地区、细分市场预测），2025 年至 2033 年

Multiomics Market Size, Share & Trends Analysis Report By Product & Service (Instruments, Consumables), By Type (Single-cell, Bulk), By Platform, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

多组体学市场成长与趋势：

根据 Grand View Research, Inc. 的最新报告，全球多组体学市场规模预计到 2033 年将达到 98.1 亿美元，2025 年至 2033 年的复合年增长率为 15.33%。

预计体学技术成本下降、私营和公共部门投资和资金筹措增加等因素将推动市场发展。此外，製药、生物技术和学术研究机构的需求成长导致市场竞争加剧，预计也将在预测期内推动市场成长。

随着技术的进步，体学技术的成本预计将下降，使研究人员更容易取得资料集，从而推动市场成长。各公司正专注于技术进步以降低成本。例如，亚马逊体学服务 (AWS) 于 2022 年 11 月宣布推出 Amazon Omics Services。该服务利用生物资讯感知储存选项来储存原始定序数据，从而降低成本。因此，较低的成本预计将使研究人员和临床医生更容易获得体学技术。这种成本降低预计将增加多体学方法的采用。

预计来自私人和公共参与者的投资和资金增加将推动对多组体学产品和服务的需求。许多公司正在大力投资多组体学平台和技术的开发。例如，2022年1月，罗氏公司向生技公司Freenome投资2.9亿美元。这笔投资用于加速其用于早期癌症检测的多组体学平台的发展。此外，2023年5月，MultiOmic Health完成了620万美元的资金筹措，用于建立精准药物发现平台。因此，预计资金筹措和投资的增加将推动市场上各种新型平台和产品的开发。

市场相关人员日益注重开发创新产品和服务，也是推动市场需求成长的关键因素。各公司正在开发新型平台，以应对日益激烈的竞争。例如，2023年2月，Via Scientific, Inc.推出了Foundry，这是一个多组体学加速器平台，支援在多组体学研究过程中自动执行复杂的数据和分析任务。预计此类产品的发布将在预测期内推动产业发展。

多组体学市场报告重点

  • 基于产品和服务部分，它将在 2024 年占据最大的市场收益占有率。预计该部分的成长将受到开发和产品发布数量激增的推动。
  • 根据类型，批量体学部分将在 2024 年占据最大的市场收益占有率。另一方面，由于对单细胞体学的需求不断增加以了解复杂的生物系统，单细胞体学预计将以最快的速度增长，在预测期内的复合年增长率为 17.8%。
  • 基于平台，基因组学将在 2024 年占据市场主导地位，收入份额为 40.63%。这一增长归因于该领域拥有大量可用的产品。
  • 根据应用，肿瘤学领域在 2024 年占据了最大的市场收益占有率。预计癌症发病率的上升和多组体学在癌症中的应用的增加将推动该领域的成长。
  • 根据最终用途，预计学术和研究机构部门将在 2024 年占据最大的市场收益占有率。相较之下，由于对多组体学的需求不断增加以加速药物发现和开发，预计製药和生物技术公司将见证最快的成长。
  • 由于该地区主要市场参与者的存在，北美在 2024 年占据了全球市场的主导地位，收益占有率为 48.76%。

目录

第一章调查方法与范围

第二章执行摘要

第三章市场变数、趋势和范围

  • 市场展望
    • 母市场展望
    • 相关/支持市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 产业分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19影响分析

第四章多组体学市场：产品与服务的商业分析

  • 细分仪表板
  • 全球体学市场：产品与服务变化分析
  • 全球多组体学市场规模与趋势分析（产品与服务，2021-2033 年）
  • 产品
  • 服务

第五章多组体学市场：业务类型分析

  • 细分仪表板
  • 全球体学市场：类型变异分析
  • 2021 年至 2033 年全球多组体学市场规模及趋势分析（按类型）
  • 单细胞多组体学
  • 批量体学

第六章 多组体学市场：平台业务分析

  • 细分仪表板
  • 全球体学市场平台变化分析
  • 2021 年至 2033 年全球多组体学市场规模及趋势分析（按平台）
  • 基因组学
  • 转录组学
  • 蛋白质体学
  • 代谢体学
  • 整合组体学平台

7. 多体学市场：应用商业分析

  • 细分仪表板
  • 全球体学市场应用趋势分析
  • 全球多体学市场规模和趋势分析（按应用，2021-2033）
  • 细胞生物学
  • 肿瘤学
  • 神经病学
  • 免疫学

8. 多组体学市场：最终用途业务分析

  • 细分仪表板
  • 全球体学市场最终用途趋势分析
  • 2021 年至 2033 年全球多组体学市场规模及趋势分析（依最终用途）
  • 学术研究所
  • 製药和生物技术公司
  • 其他的

第九章多组体学市场：区域业务分析

  • 区域仪表板
  • 2021-2033 年市场规模、预测与趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第十章 竞争格局

  • 参与企业
  • 战略地图
  • 2024年企业市场分析
  • 参与企业概况
    • BD
    • Thermo Fisher Scientific Inc.
    • Illumina, Inc
    • Danaher
    • PerkinElmer Inc.
    • Shimadzu Corporation
    • Bruker
    • QIAGEN
    • Agilent Technologies, Inc.
    • BGI
Product Code: GVR-4-68040-136-5

Multiomics Market Growth & Trends:

The global multiomics market size is estimated to reach USD 9.81 billion by 2033, expanding at a CAGR of 15.33% from 2025 to 2033, according to a new report by Grand View Research, Inc. Factors such as the decreasing costs of omics technologies and growing investment and funding from private and public players are expected to drive the market. In addition, rising competition in the market owing to increasing demand from pharmaceutical & biotechnology companies and academic research institutions is also anticipated to propel the market growth over the forecast period.

With the improvement in technologies, the cost of omics technologies is anticipated to reduce, which can increase the accessibility of datasets to researchers, consequently driving market growth. Companies are focusing on technological advancements to lower costs. For instance, in November 2022, Amazon Web Services introduced an Amazon Omics service. This service utilizes bioinformatics-aware storage options to store raw sequence data and to decrease costs. Thus, the decreasing costs are anticipated to increase the accessibility of omics technologies to researchers and clinicians. Such cost reduction is expected to increase the adoption of multiomics approaches.

The growing investments and funding from private and public participants are anticipated to boost the demand for multi-omics products and services. Various companies are significantly investing in the development of multiomics platforms and technologies. For instance, in January 2022, Roche invested USD 290 million in Freenome, a biotech company. This investment was used to accelerate multiomics platforms for early cancer detection. In addition, in May 2023, MultiOmic Health completed a funding round of USD 6.2 million to construct a precision therapeutics discovery platform. Thus, the rising funding and investments are expected to develop various novel platforms and products in the markets

The rising emphasis of market players to develop innovative products and services is another vital factor propelling market demand forward. Various companies are developing novel platforms to sustain the rising competition. For instance, in February 2023, Via Scientific, Inc. introduced a multi-omics accelerator platform, Foundry, that supports the automation of complex data and analytical work during multi-omics research. Such product launches are anticipated to drive the industry over the forecast period.

Multiomics Market Report Highlights:

  • Based on the product segment accounted for the largest market revenue share in 2024. The segment's growth is anticipated to be driven by the development surge and the number of product launches.
  • Based on type, the bulk multiomics segment accounted for the largest market revenue share in 2024. In contrast, single-cell multi-omics is expected to grow at the fastest CAGR of 17.8% over the forecast period, due to increasing demand for single-cell multi-omics to comprehend complex biology systems
  • Based on platform, genomics dominated the market with a revenue share of 40.63% in 2024. The growth is attributed to the high number of products available in this segment
  • Based on application, the oncology segment accounted for the largest market revenue share in 2024. The rising incidence of cancer and the growing use of multi-omics for cancer are anticipated to drive segment growth.
  • Based on end-use, the academic & research institutes segment accounted for the largest market revenue share in 2024. In contrast, pharmaceutical and biotechnology companies are expected to witness the fastest growth owing to increasing demand for multi-omics to accelerate drug discovery and development
  • North America dominated the global industry in 2024 with a revenue share of 48. 76%, owing to the presence of key market players in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product & Service
    • 1.2.2. Type
    • 1.2.3. Platform
    • 1.2.4. Application
    • 1.2.5. End-use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Multiomics Market: Product & Service Business Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Multiomics Market Product & Service Movement Analysis
  • 4.3. Global Multiomics Market Size & Trend Analysis, by Product & Service, 2021 to 2033 (USD Million)
  • 4.4. Product
    • 4.4.1. Global Product Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Instruments
      • 4.4.2.1. Global Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Consumables
      • 4.4.3.1. Global Consumables Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.4. Software
      • 4.4.4.1. Global Software Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Services
    • 4.5.1. Global Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Multiomics Market: Type Business Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Multiomics Market Type Movement Analysis
  • 5.3. Global Multiomics Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
  • 5.4. Single-cell Multiomics
    • 5.4.1. Global Single-cell Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Bulk Multiomics
    • 5.5.1. Global Bulk Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Multiomics Market: Platform Business Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Multiomics Market Platform Movement Analysis
  • 6.3. Global Multiomics Market Size & Trend Analysis, by Platform, 2021 to 2033 (USD Million)
  • 6.4. Genomics
    • 6.4.1. Global Genomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Transcriptomics
    • 6.5.1. Global Transcriptomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Proteomics
    • 6.6.1. Global Proteomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Metabolomics
    • 6.7.1. Global Metabolomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Integrated Omics Platforms
    • 6.8.1. Global Integrated Omics Platforms Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Multiomics Market: Application Business Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Multiomics Market Application Movement Analysis
  • 7.3. Global Multiomics Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 7.4. Cell Biology
    • 7.4.1. Global Cell Biology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Oncology
    • 7.5.1. Global Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Neurology
    • 7.6.1. Global Neurology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Immunology
    • 7.7.1. Global Immunology Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Multiomics Market: End-use Business Analysis

  • 8.1. Segment Dashboard
  • 8.2. Global Multiomics Market End-use Movement Analysis
  • 8.3. Global Multiomics Market Size & Trend Analysis, by End-use, 2021 to 2033 (USD Million)
  • 8.4. Academic and Research Institutes
    • 8.4.1. Global Academic and Research Institutes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Pharmaceutical & Biotechnology Companies
    • 8.5.1. Global Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Others
    • 8.6.1. Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Multiomics Market: Regional Estimates & Trend Analysis by Product & Service, Type, Platform, Application, & End-use

  • 9.1. Regional Dashboard
  • 9.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
  • 9.3. North America
    • 9.3.1. North America Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.3.2. U.S.
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Competitive Scenario
      • 9.3.2.3. Regulatory Framework
      • 9.3.2.4. U.S. Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.3.3. Canada
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Competitive Scenario
      • 9.3.3.3. Regulatory Framework
      • 9.3.3.4. Canada Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.3.4. Mexico
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Competitive Scenario
      • 9.3.4.3. Regulatory Framework
      • 9.3.4.4. Mexico Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4. Europe
    • 9.4.1. Europe Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.2. UK
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Competitive Scenario
      • 9.4.2.3. Regulatory Framework
      • 9.4.2.4. UK Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.3. Germany
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Competitive Scenario
      • 9.4.3.3. Regulatory Framework
      • 9.4.3.4. Germany Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.4. France
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Competitive Scenario
      • 9.4.4.3. Regulatory Framework
      • 9.4.4.4. France Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.5. Italy
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Competitive Scenario
      • 9.4.5.3. Regulatory Framework
      • 9.4.5.4. Italy Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.6. Spain
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Competitive Scenario
      • 9.4.6.3. Regulatory Framework
      • 9.4.6.4. Spain Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.7. Denmark
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Competitive Scenario
      • 9.4.7.3. Regulatory Framework
      • 9.4.7.4. Denmark Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.8. Sweden
      • 9.4.8.1. Key Country Dynamics
      • 9.4.8.2. Competitive Scenario
      • 9.4.8.3. Regulatory Framework
      • 9.4.8.4. Sweden Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.9. Norway
      • 9.4.9.1. Key Country Dynamics
      • 9.4.9.2. Competitive Scenario
      • 9.4.9.3. Regulatory Framework
      • 9.4.9.4. Norway Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5. Asia Pacific
    • 9.5.1. Asia Pacific Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.5.2. Japan
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Competitive Scenario
      • 9.5.2.3. Regulatory Framework
      • 9.5.2.4. Japan Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.5.3. China
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Competitive Scenario
      • 9.5.3.3. Regulatory Framework
      • 9.5.3.4. China Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.5.4. India
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Competitive Scenario
      • 9.5.4.3. Regulatory Framework
      • 9.5.4.4. India Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.5.5. Australia
      • 9.5.5.1. Key Country Dynamics
      • 9.5.5.2. Competitive Scenario
      • 9.5.5.3. Regulatory Framework
      • 9.5.5.4. Australia Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.5.6. Thailand
      • 9.5.6.1. Key Country Dynamics
      • 9.5.6.2. Competitive Scenario
      • 9.5.6.3. Regulatory Framework
      • 9.5.6.4. Thailand Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.5.7. South Korea
      • 9.5.7.1. Key Country Dynamics
      • 9.5.7.2. Competitive Scenario
      • 9.5.7.3. Regulatory Framework
      • 9.5.7.4. South Korea Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.6. Latin America
    • 9.6.1. Latin America Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.6.2. Brazil
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Competitive Scenario
      • 9.6.2.3. Regulatory Framework
      • 9.6.2.4. Brazil Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.6.3. Argentina
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Competitive Scenario
      • 9.6.3.3. Regulatory Framework
      • 9.6.3.4. Argentina Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7. MEA
    • 9.7.1. MEA Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.7.2. South Africa
      • 9.7.2.1. Key Country Dynamics
      • 9.7.2.2. Competitive Scenario
      • 9.7.2.3. Regulatory Framework
      • 9.7.2.4. South Africa Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.7.3. Saudi Arabia
      • 9.7.3.1. Key Country Dynamics
      • 9.7.3.2. Competitive Scenario
      • 9.7.3.3. Regulatory Framework
      • 9.7.3.4. Saudi Arabia Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.7.4. UAE
      • 9.7.4.1. Key Country Dynamics
      • 9.7.4.2. Competitive Scenario
      • 9.7.4.3. Regulatory Framework
      • 9.7.4.4. UAE Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.7.5. Kuwait
      • 9.7.5.1. Key Country Dynamics
      • 9.7.5.2. Competitive Scenario
      • 9.7.5.3. Regulatory Framework
      • 9.7.5.4. Kuwait Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Participant Categorization
  • 10.2. Strategy Mapping
  • 10.3. Company Market Position Analysis, 2024
  • 10.4. Participant's Overview
    • 10.4.1. BD
      • 10.4.1.1. Overview
      • 10.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.1.3. Product Benchmarking
      • 10.4.1.4. Strategic Initiatives
    • 10.4.2. Thermo Fisher Scientific Inc.
      • 10.4.2.1. Overview
      • 10.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.2.3. Product Benchmarking
      • 10.4.2.4. Strategic Initiatives
    • 10.4.3. Illumina, Inc
      • 10.4.3.1. Overview
      • 10.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.3.3. Product Benchmarking
      • 10.4.3.4. Strategic Initiatives
    • 10.4.4. Danaher
      • 10.4.4.1. Overview
      • 10.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.4.3. Product Benchmarking
      • 10.4.4.4. Strategic Initiatives
    • 10.4.5. PerkinElmer Inc.
      • 10.4.5.1. Overview
      • 10.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.5.3. Product Benchmarking
      • 10.4.5.4. Strategic Initiatives
    • 10.4.6. Shimadzu Corporation
      • 10.4.6.1. Overview
      • 10.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.6.3. Product Benchmarking
      • 10.4.6.4. Strategic Initiatives
    • 10.4.7. Bruker
      • 10.4.7.1. Overview
      • 10.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.7.3. Product Benchmarking
      • 10.4.7.4. Strategic Initiatives
    • 10.4.8. QIAGEN
      • 10.4.8.1. Overview
      • 10.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.8.3. Product Benchmarking
      • 10.4.8.4. Strategic Initiatives
    • 10.4.9. Agilent Technologies, Inc.
      • 10.4.9.1. Overview
      • 10.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.9.3. Product Benchmarking
      • 10.4.9.4. Strategic Initiatives
    • 10.4.10. BGI
      • 10.4.10.1. Overview
      • 10.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.10.3. Product Benchmarking
      • 10.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 4 Global multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 5 Global multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 6 Global multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 7 Global multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 8 Global multiomics market, by region, 2021 - 2033 (USD Million)
  • Table 9 North America multiomics market, by country, 2021 - 2033 (USD Million)
  • Table 10 North America multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 11 North America multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 12 North America multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 13 North America multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 14 North America multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 15 U.S. multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 16 U.S. multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 17 U.S. multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 18 U.S. multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 19 U.S. multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 20 Canada multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 21 Canada multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 22 Canada multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 23 Canada multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 24 Canada multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 25 Mexico multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 26 Mexico multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 27 Mexico multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 28 Mexico multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 29 Mexico multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 30 Europe multiomics market, by country, 2021 - 2033 (USD Million)
  • Table 31 Europe multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 32 Europe multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 33 Europe multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 34 Europe multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 35 Europe multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 36 UK multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 37 UK multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 38 UK multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 39 UK multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 40 UK multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 41 Germany multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 42 Germany multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 43 Germany multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 44 Germany multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 45 Germany multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 46 France multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 47 France multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 48 France multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 49 France multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 50 France multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 51 Italy multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 52 Italy multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 53 Italy multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 54 Italy multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 55 Italy multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 56 Spain multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 57 Spain multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 58 Spain multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 59 Spain multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 60 Spain multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 61 Denmark multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 62 Denmark multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 63 Denmark multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 64 Denmark multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 65 Denmark multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 66 Sweden multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 67 Sweden multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 68 Sweden multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 69 Sweden multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 70 Sweden multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 71 Norway multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 72 Norway multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 73 Norway multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 74 Norway multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 75 Norway multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 76 Asia Pacific multiomics market, by country, 2021 - 2033 (USD Million)
  • Table 77 Asia Pacific multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 78 Asia Pacific multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 79 Asia Pacific multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 80 Asia Pacific multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 81 Asia Pacific multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 82 Japan multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 83 Japan multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 84 Japan multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 85 Japan multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 86 Japan multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 87 China multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 88 China multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 89 China multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 90 China multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 91 China multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 92 India multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 93 India multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 94 India multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 95 India multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 96 India multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 97 Australia multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 98 Australia multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 99 Australia multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 100 Australia multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 101 Australia multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 102 Thailand multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 103 Thailand multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 104 Thailand multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 105 Thailand multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 106 Thailand multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 107 South Korea multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 108 South Korea multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 109 South Korea multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 110 South Korea multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 111 South Korea multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 112 Latin America multiomics market, by country, 2021 - 2033 (USD Million)
  • Table 113 Latin America multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 114 Latin America multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 115 Latin America multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 116 Latin America multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 117 Latin America multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 118 Brazil multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 119 Brazil multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 120 Brazil multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 121 Brazil multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 122 Brazil multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 123 Argentina multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 124 Argentina multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 125 Argentina multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 126 Argentina multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 127 Argentina multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 128 Middle East & Africa multiomics market, by country, 2021 - 2033 (USD Million)
  • Table 129 Middle East & Africa multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 130 Middle East & Africa multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 131 Middle East & Africa multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 132 Middle East & Africa multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 133 Middle East & Africa multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 134 South Africa multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 135 South Africa multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 136 South Africa multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 137 South Africa multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 138 South Africa multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 139 Saudi Arabia multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 140 Saudi Arabia multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 141 Saudi Arabia multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 142 Saudi Arabia multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 143 Saudi Arabia multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 144 UAE multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 145 UAE multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 146 UAE multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 147 UAE multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 148 UAE multiomics market, by end-use, 2021 - 2033 (USD Million)
  • Table 149 Kuwait multiomics market, by product & service, 2021 - 2033 (USD Million)
  • Table 150 Kuwait multiomics market, by type, 2021 - 2033 (USD Million)
  • Table 151 Kuwait multiomics market, by platform, 2021 - 2033 (USD Million)
  • Table 152 Kuwait multiomics market, by application, 2021 - 2033 (USD Million)
  • Table 153 Kuwait multiomics market, by end-use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Multiomics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market outlook
  • Fig. 8 Segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Multiomics market driver analysis
  • Fig. 12 Multiomics market restraint analysis
  • Fig. 13 Multiomics market: Porter's analysis
  • Fig. 14 Multiomics market: PESTEL analysis
  • Fig. 15 Multiomics market: Product & service outlook and key takeaways
  • Fig. 16 Multiomics market: Product & service market share analysis, 2024 - 2033
  • Fig. 17 Global multiomics by products market, 2021 - 2033 (USD Million)
  • Fig. 18 Global multiomics by instruments market, 2021 - 2033 (USD Million)
  • Fig. 19 Global multiomics by consumables market, 2021 - 2033 (USD Million)
  • Fig. 20 Global multiomics by software market, 2021 - 2033 (USD Million)
  • Fig. 21 Global multiomics by services market, 2021 - 2033 (USD Million)
  • Fig. 22 Multiomics market: Type outlook and key takeaways
  • Fig. 23 Multiomics market: Type market share analysis, 2024 - 2033
  • Fig. 24 Global single-cell multiomics by men market, 2021 - 2033 (USD Million)
  • Fig. 25 Global multiomics by bulk multiomics market, 2021 - 2033 (USD Million)
  • Fig. 26 Multiomics market: Platform outlook and key takeaways
  • Fig. 27 Multiomics market: Platform market share analysis, 2024 - 2033
  • Fig. 28 Global multiomics by genomics market, 2021 - 2033 (USD Million)
  • Fig. 29 Global multiomics by transcriptomics market, 2021 - 2033 (USD Million)
  • Fig. 30 Global multiomics by proteomics market, 2021 - 2033 (USD Million)
  • Fig. 31 Global multiomics by metabolomics market, 2021 - 2033 (USD Million)
  • Fig. 32 Global multiomics by integrated omics platforms market, 2021 - 2033 (USD Million)
  • Fig. 33 Multiomics market: Application outlook and key takeaways
  • Fig. 34 Multiomics market: Application market share analysis, 2024 - 2033
  • Fig. 35 Global multiomics by cell biology market, 2021 - 2033 (USD Million)
  • Fig. 36 Global multiomics by oncology market, 2021 - 2033 (USD Million)
  • Fig. 37 Global multiomics by neurology market, 2021 - 2033 (USD Million)
  • Fig. 38 Global multiomics by immunology market, 2021 - 2033 (USD Million)
  • Fig. 39 Multiomics market: End-use outlook and key takeaways
  • Fig. 40 Multiomics market: End-use market share analysis, 2024 - 2033
  • Fig. 41 Global multiomics by academic and research institutes market, 2021 - 2033 (USD Million)
  • Fig. 42 Global multiomics by pharmaceutical & biotechnology companies market, 2021 - 2033 (USD Million)
  • Fig. 43 Global multiomics by others market, 2021 - 2033 (USD Million)
  • Fig. 44 Regional marketplace: Key takeaways
  • Fig. 45 North America multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 46 U.S. key country dynamics
  • Fig. 47 U.S. multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 48 Canada key country dynamics
  • Fig. 49 Canada multiomics market, 2021 - 2033 (USD Million)
  • Fig. 50 Europe multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 51 UK key country dynamics
  • Fig. 52 UK multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 53 Germany key country dynamics
  • Fig. 54 Germany multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 55 France key country dynamics
  • Fig. 56 France multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 57 Italy key country dynamics
  • Fig. 58 Italy multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 59 Spain key country dynamics
  • Fig. 60 Spain multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 61 Denmark key country dynamics
  • Fig. 62 Denmark multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 63 Sweden key country dynamics
  • Fig. 64 Sweden multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 65 Norway key country dynamics
  • Fig. 66 Norway multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 67 Asia-Pacific multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 68 Japan key country dynamics
  • Fig. 69 Japan multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 70 China key country dynamics
  • Fig. 71 China multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 72 India key country dynamics
  • Fig. 73 India multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 74 Australia key country dynamics
  • Fig. 75 Australia multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 76 Thailand key country dynamics
  • Fig. 77 Thailand multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 78 South Korea key country dynamics
  • Fig. 79 South Korea multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 80 Latin America multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 81 Brazil key country dynamics
  • Fig. 82 Brazil multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 83 Mexico key country dynamics
  • Fig. 84 Mexico multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 85 Argentina key country dynamics
  • Fig. 86 Argentina multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 87 MEA multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 88 South Africa key country dynamics
  • Fig. 89 South Africa multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 90 Saudi Arabia key country dynamics
  • Fig. 91 Saudi Arabia multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 92 UAE key country dynamics
  • Fig. 93 UAE multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 94 Kuwait key country dynamics
  • Fig. 95 Kuwait multiomics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 96 Key company categorization
  • Fig. 97 Company market positioning
  • Fig. 98 Market participant categorization
  • Fig. 99 Strategy framework